Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
Estimated number of participants: 342 participants with COVID-19 Design: Phase III,
single-center, randomized, double-blind, parallel, placebo-controlled clinical study.
Phase:
Phase 3
Details
Lead Sponsor:
HRH Holdngs Limited HRH Pharmaceuticals Limited
Collaborators:
GALZU INSTITUTE OF RESEARCH, TEACHING, SCIENCE AND APPLIED TECHNOLOGY, Brazil SANTA CASA DE MISERICORDIA DE CAMPOS HOSPITAL (SCMCH), Brazil UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE (UENF), Brazil